Release Date: 31/01/19 19:27 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 2.67MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%